Lotus Eye Hospital & Institute Ltd

As of 17-Nov, Lotus Eye Hospital & Institute Ltd's stock price is declining at 106.50, down 4.01% and has fallen 11.95% over the last three days. Despite strong year-to-date and annual performance, it has significantly underperformed compared to the market and its sector recently.

Lotus Eye Hospital has experienced revenue growth from INR 32.37 crore in March 2021 to INR 49.56 crore in March 2025, but profitability has declined, with profit after tax dropping from INR 4.08 crore to INR 0.74 crore during the same period, alongside decreasing cash flow. Total assets and liabilities have both increased, indicating financial strain despite rising sales.

As of 13-Nov, Lotus Eye Hospital & Institute Ltd's stock price is at 115.00, down 4.92% and underperforming its sector. Despite a strong year-to-date performance, recent declines in stock price and delivery volume indicate challenges that diverge from broader market trends.

Lotus Eye Hospital has experienced revenue growth, with net sales increasing from INR 32.37 crore in March 2021 to INR 49.56 crore in March 2025. However, profitability has declined, with profit after tax dropping from INR 4.08 crore in March 2023 to INR 0.74 crore in March 2025 due to rising expenditures.

As of 06-Nov, Lotus Eye Hospital & Institute Ltd is priced at 124.50, down 0.6%, but has seen a year-to-date increase of 80.88%. Despite recent declines, the stock has outperformed the market, indicating strong relative strength.

As of 03-Nov, Lotus Eye Hospital & Institute Ltd is currently priced at Rs 130.35, reflecting a 4.99% increase and strong performance, outperforming its sector and the benchmark Sensex significantly. The stock has shown consistent gains, rising 9.86% over the last three days, with increased investor interest indicated by a 38.99% rise in delivery volume.

As of 24-Sep, Lotus Eye Hospital & Institute Ltd's stock price is 120.05, down 0.46%, with recent performance lagging behind the Sensex despite a significant year-to-date increase of 74.42%. The stock is currently below its short-term moving averages and has seen a drop in investor participation.

As of 23-Sep, Lotus Eye Hospital & Institute Ltd is seeing a price increase to Rs 122.00, reflecting a 2.26% rise. The stock has shown resilience with a 62.67% annual return, outperforming the BSE500 index, despite a recent drop in investor participation.

As of 22-Sep, Lotus Eye Hospital & Institute Ltd is priced at 119.25, down 0.21%. Despite a recent short-term decline, the stock has strong long-term performance with a 73.25% year-to-date increase, though reduced investor participation may affect near-term price stability.

As of 18-Sep, Lotus Eye Hospital & Institute Ltd is priced at 123.00, having increased by 0.61%. The stock has shown strong performance with a 48.48% rise over the past month and 64.55% over the past year, but a significant drop in delivery volume may raise concerns about future trading activity.

As of 17-Sep, Lotus Eye Hospital & Institute Ltd is priced at 122.25, reflecting a recent increase but showing a decline in investor participation with a 17.47% drop in delivery volume. Despite strong long-term performance, the stock's recent short-term underperformance suggests a mixed outlook in the current market.

As of 16-Sep, Lotus Eye Hospital & Institute Ltd's stock price has declined to Rs 121.30, down 3.19%, underperforming its sector and showing a 6.66% drop over the past week. Despite significant long-term gains, decreased delivery volume indicates falling investor participation, contributing to the current price drop.

As of 15-Sep, Lotus Eye Hospital & Institute Ltd is currently priced at Rs 125.30, reflecting a recent increase and strong long-term performance, with an 82.04% year-to-date return. Despite a slight decline over the past week, it has significantly outperformed the benchmark Sensex, indicating positive investor sentiment and strong performance metrics.

As of 12-Sep, Lotus Eye Hospital & Institute Ltd's stock price is 122.50, reflecting a 0.41% rise after two days of decline. Despite a recent drop in delivery volume, the stock has shown strong long-term performance with a 61.72% return over the past year, significantly outperforming the BSE500 index.

As of 11-Sep, Lotus Eye Hospital & Institute Ltd's stock price is declining at 122.00, down 1.57%, with a total drop of 6.12% over the last two days. Despite strong long-term performance, recent selling pressure and reduced trading activity indicate short-term challenges.